Inferior Vena Cava Filters in Recurrent Thromboembolism: Yes or No?

Courtesy of Dr. Guillermo Migliaro.

vena cava filters, pulmonary embolism, deep vein thrombosisAt present, there is no clear evidence in favor of inferior vena cava filters (IVC) for patients developing recurrent symptomatic venous thromboembolism (VTE), and the existing guideline recommendations from the different societies are contradicting.

 

The aim of this study was to assess the effectiveness of these devices in patients with recurrent VTE on anticoagulant therapy. The study incorporated patients with IVC filters for recurrent venous thromboembolism in the first three months of anticoagulant therapy from the RIETE registry (Registro Informatizado de la Enfermedad Tromboembólica) and locked at mortality outcomes 30 days after diagnosis, as follows:

  • all cause
  • pulmonary embolism related
  • second recurrent venous thromboembolism episode
  • major bleeding

 

Among 17 patients treated with filters and 49 matched patients treated without filters for VTE recurrence that presented as deep vein thrombosis, propensity score matching showed no significant differences in mortality (17.7% vs. 12.2%; p = 0.56).

 

When recurrent thromboembolism presented as pulmonary embolism (48 with VCF and 91 matched patients treated without VCF) there was a significant reduction in all-cause mortality: 2.1% vs. 25.3%; p = 0.02).

 

Pulmonary embolism related mortality was not significantly lower in the VCF group (2.1% vs. 17.6%; p = 0.08).

 

The authors concluded that, during the first three months of anticoagulation therapy, VCF placement in patients with recurrent VTE was associated to a benefit in survival rate in patients presenting pulmonary embolism..

 

Editorial Comment

Surprisingly, there is little evidence on inferior vena cava filters in patients with recurrent thromboembolism. The study sheds some light on a scarcely studied matter. The number of patients is small and the cause behind recurrent thromboembolism has not yet been determined and, although VCFs seem to be somewhat beneficial for patients with pulmonary embolism, the evidence is not enough for us to advocate for filters.

 

Courtesy of Dr. Guillermo Migliaro. German Hospital, Buenos Aires, Argentina.

 

Original Title: Outcomes Associated with Inferior Vena Cava Filters among Patients with Thromboembolic Recurrence During Anticoagulant Therapy.

Reference: M Mellado et al. JACC Cardiovasc Interv. 2016 Nov 3.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

Conservative management of endoleaks in complex aortic endografts under CT angiography follow-up

Endoleaks remain one of the leading causes of reintervention after endovascular repair of complex aortic aneurysms using fenestrated and/or branched endografts (F/B-EVAR). Traditionally, type...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...